«World's first genetic
modification of human embryos reported: Experts consider ethics.»
Relaxing the ban on genetic
modification of human embryos is just one of the controversial suggestions contained in a report issued today by the United Kingdom's House of Commons Science and Technology committee.
Britain on Monday granted its first licence for the genetic
modification of human embryos as part of research into infertility and why miscarriages happen, in a move likely to raise ethical concerns.
Not exact matches
Because
of the legislation, a FDA spokesperson noted in an email, «the agency will not receive or review INDs [Investigational New Drug applications] for
human subject research utilizing genetic
modification of embryos for the prevention
of transmission
of mitochondrial disease in FY 2016 and
human subject research using these technologies can not be conducted in compliance with the Federal Food, Drug, and Cosmetic Act and FDA's implementing regulations.»
In particular, they ask why the US - based team behind the operation chose to carry it out in Mexico, a country with less - clear oversight
of human embryo modification than, for instance, the United Kingdom or the United States.
«We believe that any attempt to generate genetically modified
humans through the
modification of early
embryos needs to be strictly prohibited until we can resolve both ethical and scientific issues,» they write.
«Germline editing» — genetic
modification of human cells, including
embryos, eggs and sperm, that can be passed to future generations — has been controversial.
But he thinks that US scientists will inevitably take on such research, although federal funding
of research on
human embryos and germline
modification is prohibited.
Marson stressed that, while recent reports
of CRISPR / Cas9 editing
of human embryos have stirred up controversy, T cells are created anew in each individual, so
modifications would not be passed on to future generations.
As such,
human subject research utilizing genetic
modification of embryos for the prevention
of transmission
of mitochondrial disease can not be performed in the United States in FY 2016» [3].
Great Britain's
Human Fertilisation and Embryology Authority (HFEA), which oversees fertility treatments and
embryo research in that nation, recently approved fertility procedures that would amount to the genetic engineering
of children through cloning (nuclear transfer) technology and germ - line
modification, resulting in a «three - parent
embryo» that would have genetic material from two mothers and one father.